Request Sample Inquiry
Naloxone Market

Naloxone Market

Naloxone Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

Base Year:

2022

Date

Sep - 2023

Format:

PDF XLS PPT

Report Code:

VMR-VMR-2021-0530

Segments Covered
  • By Route of Administration By Route of Administration Injectables, Nasal, Oral
  • By Strength By Strength 0.02mg/ml, 1mg/ml, 0.4mg/ml, Others
  • By Distribution channel By Distribution channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1119.6 Million
Revenue 2030Revenue 2030: USD 2617.6 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 11.2%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Naloxone Market - Segment Analysis
    1. Overview
    2. Global Naloxone Market, 2016 - 2028 (USD Million)
    3. Global Naloxone Market - by Route of Administration
      1. By Injectables
      2. By Nasal
      3. By Oral
    4. Global Naloxone Market - by Strength
      1. By 0.02mg/ml
      2. By 1mg/ml
      3. By 0.4mg/ml
      4. By Others
    5. Global Naloxone Market - by Distribution channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Others
    6. Global Naloxone Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Naloxone Market - Segment Analysis
    1. Overview
    2. North America Naloxone Market, 2016 - 2028 (USD Million)
    3. North America Naloxone Market, by Route of Administration
      1. By Injectables
      2. By Nasal
      3. By Oral
    4. North America Naloxone Market, by Strength
      1. By 0.02mg/ml
      2. By 1mg/ml
      3. By 0.4mg/ml
      4. By Others
    5. North America Naloxone Market, by Distribution channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Others
    6. North America Naloxone Market, by Country
      1. U.S.
        1. U.S. Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. U.S. Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. U.S. Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      2. Canada
        1. Canada Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Canada Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Canada Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      3. Mexico
        1. Mexico Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Mexico Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Mexico Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
  5. Europe Naloxone Market - Segment Analysis
    1. Overview
    2. Europe Naloxone Market, 2016 - 2028 (USD Million)
    3. Europe Naloxone Market, by Route of Administration
      1. By Injectables
      2. By Nasal
      3. By Oral
    4. Europe Naloxone Market, by Strength
      1. By 0.02mg/ml
      2. By 1mg/ml
      3. By 0.4mg/ml
      4. By Others
    5. Europe Naloxone Market, by Distribution channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Others
    6. Europe Naloxone Market, by Country
      1. Germany
        1. Germany Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Germany Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Germany Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      2. UK
        1. UK Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. UK Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. UK Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      3. France
        1. France Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. France Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. France Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      4. Spain
        1. Spain Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Spain Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Spain Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      5. Italy
        1. Italy Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Italy Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Italy Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      6. BENELUX
        1. BENELUX Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. BENELUX Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. BENELUX Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      7. Rest of Europe
        1. Rest Of Europe Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Rest Of Europe Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Rest Of Europe Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
  6. Asia Pacific Naloxone Market - Segment Analysis
    1. Overview
    2. Asia Pacific Naloxone Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Naloxone Market, by Route of Administration
      1. By Injectables
      2. By Nasal
      3. By Oral
    4. Asia Pacific Naloxone Market, by Strength
      1. By 0.02mg/ml
      2. By 1mg/ml
      3. By 0.4mg/ml
      4. By Others
    5. Asia Pacific Naloxone Market, by Distribution channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Others
    6. Asia Pacific Naloxone Market, by Country
      1. China
        1. China Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. China Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. China Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      2. Japan
        1. Japan Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Japan Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Japan Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      3. India
        1. India Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. India Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. India Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      4. South Korea
        1. South Korea Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. South Korea Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. South Korea Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      5. South East Asia
        1. South East Asia Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. South East Asia Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. South East Asia Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Rest of Asia Pacific Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Rest of Asia Pacific Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
  7. Latin America Naloxone Market - Segment Analysis
    1. Overview
    2. Latin America Naloxone Market, 2016 - 2028 (USD Million)
    3. Latin America Naloxone Market, by Route of Administration
      1. By Injectables
      2. By Nasal
      3. By Oral
    4. Latin America Naloxone Market, by Strength
      1. By 0.02mg/ml
      2. By 1mg/ml
      3. By 0.4mg/ml
      4. By Others
    5. Latin America Naloxone Market, by Distribution channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Others
    6. Latin America Naloxone Market, by Country
      1. Brazil
        1. Brazil Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Brazil Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Brazil Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      2. Argentina
        1. Argentina Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Argentina Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Argentina Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      3. Rest of Latin America
        1. Rest of Latin America Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Rest of Latin America Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Rest of Latin America Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
  8. Middle East & Africa Naloxone Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Naloxone Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Naloxone Market, by Route of Administration
      1. By Injectables
      2. By Nasal
      3. By Oral
    4. Middle East & Africa Naloxone Market, by Strength
      1. By 0.02mg/ml
      2. By 1mg/ml
      3. By 0.4mg/ml
      4. By Others
    5. Middle East & Africa Naloxone Market, by Distribution channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Others
    6. Middle East & Africa Naloxone Market, by Country
      1. GCC Countries
        1. GCC Countries Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. GCC Countries Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. GCC Countries Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      2. South Africa
        1. South Africa Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. South Africa Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. South Africa Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Naloxone Market, By Route of Administration
          1. By Injectables
          2. By Nasal
          3. By Oral
        2. Rest of Middle East & Africa Naloxone Market, By Strength
          1. By 0.02mg/ml
          2. By 1mg/ml
          3. By 0.4mg/ml
          4. By Others
        3. Rest of Middle East & Africa Naloxone Market, By Distribution channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Pfizer
    2. West Ward Pharmaceuticals
    3. Amneal Pharmaceuticals
    4. Sandoz
    5. ADAPT Pharma
    6. Mylan
    7. kaleo
    8. Amphastar Pharmaceuticals
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Naloxone valued at USD 1119.6 Million in 2022 and is expected to reach USD 2617.6 Million in 2030 growing at a CAGR of 11.2%.

  • The prominent players in the market are Pfizer,West Ward Pharmaceuticals,Amneal Pharmaceuticals,Sandoz,ADAPT Pharma,Mylan,kaleo,Amphastar Pharmaceuticals.

  • The market is project to grow at a CAGR of 11.2% between 2023 and 2030.

  • The driving factors of the Naloxone include

  • North America was the leading regional segment of the Naloxone in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy